Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00442533
Status:
COMPLETED
Last Update Posted:
2023-04-03
First Post:
2007-03-01
Brief Title:
Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
Sponsor:
Radio Isotope Therapy of America
Organization:
Radio Isotope Therapy of America
Organization Data
Organization:
Radio Isotope Therapy of America
Class:
OTHER
Study ID:
06-2247
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Radio Isotope Therapy of America
Lead Sponsor Class:
OTHER
Responsible Party:
Ebrahim Delpassand
Responsible Party Title:
President and CEO
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Radio Isotope Therapy of America
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| CHI St Lukes Health Texas | OTHER |
| Excel Diagnostic Imaging Clinics | UNKNOWN |
| Radiomedix Inc | INDUSTRY |